T1	Participants 234 287	patients with locally advanced cervical cancer (LACC)
T2	Participants 472 606	4 patients with International Federation of Gynecology and Obstetrics (FIGO 2009) stage IIB-IIIB squamous cell carcinoma of the cervix
